“Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE)” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s106. doi:10.25251/skin.4.supp.106.